| Chronic Lymphocytic Leukemia |
1 |
1 |
| Clinical Guidelines |
0 |
0.56 |
| Non-Hodgkin Lymphoma (NHL) |
0 |
0.55 |
| Leukemia |
0 |
0.51 |
| Breast Cancer |
0 |
0.36 |
| B-Cell Lymphoma |
0 |
0.32 |
| Pancreatic Cancer |
0 |
0.28 |
| CT Scan |
0 |
0.26 |
| Care and Maintenance of Vision |
0 |
0.23 |
| Ovarian Cancer |
0 |
0.23 |
| Hematuria |
0 |
0.22 |
| Hemoglobin |
0 |
0.22 |
| Lymphocytes |
0 |
0.22 |
| Lymphoma |
0 |
0.22 |
| Platelet Count |
0 |
0.22 |
| Cataract |
0 |
0.21 |
| Adenocarcinoma of the Pancreas |
0 |
0.16 |
| Combination Chemotherapy |
0 |
0.16 |
| A-Scan Biometry |
0 |
0.11 |
| Adenocarcinoma |
0 |
0.11 |
| Bladder |
0 |
0.11 |
| BRCA |
0 |
0.11 |
| Cancer |
0 |
0.11 |
| Chemotherapy |
0 |
0.11 |
| Flow Cytometry |
0 |
0.11 |
| Lymphadenopathy |
0 |
0.11 |
| Prognosis |
0 |
0.11 |
| Salvage Therapy |
0 |
0.11 |
| Scan |
0 |
0.11 |
| Surgery |
0 |
0.11 |